Tff Pharmaceuticals Inc (TFFP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,759 | -10,214 | -5,735 | -21,243 | -16,481 |
| Depreciation Amortization | 422 | 281 | 140 | 503 | 372 |
| Accounts receivable | N/A | N/A | 128 | N/A | N/A |
| Accounts payable and accrued liabilities | 608 | 400 | 707 | 38 | 67 |
| Other Working Capital | 2,624 | 1,767 | 1,851 | 1,526 | 1,161 |
| Other Operating Activity | 1,728 | 1,368 | -236 | 3,138 | 3,056 |
| Operating Cash Flow | $-8,377 | $-6,398 | $-3,144 | $-16,038 | $-11,825 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -95 | -48 |
| Investing Cash Flow | $0 | $N/A | $N/A | $-95 | $-48 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,629 | 5,409 | 916 | 5,125 | 5,090 |
| Other Financing Activity | -105 | -83 | -15 | -112 | -77 |
| Financing Cash Flow | $5,525 | $5,326 | $901 | $5,013 | $5,013 |
| Exchange Rate Effect | -19 | -19 | -23 | -15 | -27 |
| Beginning Cash Position | 5,478 | 5,478 | 5,478 | 16,612 | 16,612 |
| End Cash Position | 2,607 | 4,387 | 3,212 | 5,478 | 9,726 |
| Net Cash Flow | $-2,872 | $-1,091 | $-2,266 | $-11,134 | $-6,887 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,377 | -6,398 | -3,144 | -16,038 | -11,825 |
| Capital Expenditure | 0 | N/A | N/A | -95 | -48 |
| Free Cash Flow | -8,377 | -6,398 | -3,144 | -16,133 | -11,873 |